On This Page – Quick Medical Summary
What an A1C test costs, and what actually decides it
There is no single national price for an A1C test, and any page that gives you one is guessing. What you pay is decided by two things: whether you have coverage, and why the test was ordered in the first place.
That second one surprises people. The same vial of blood, run on the same machine, can be billed two completely different ways depending on the reason written on the lab order before the needle goes in.
Start where your situation fits:
If you have not had the test yet
You have an order in hand and want to know the damage before you go. Sections two through four explain which billing route you are on and what your plan has to cover.
If a bill has already arrived
You believed this was covered and it wasn’t, or not fully. Section three explains how that happens without anyone making a mistake, and section four gives you the vocabulary to check whether the bill is correct.
If you have no insurance, or are paying cash
Section six is written for you and works on its own. You have a written, enforceable right to a price before the draw, and most people have never been told it exists.
If you are on Medicare, or managing a parent’s care
Section five covers both Medicare routes, which usually end at no cost to you but for two entirely different reasons with two different conditions attached.
ℹ️ Medical Disclaimer: This article explains how A1C testing is billed and covered in the United States. It does not diagnose any condition, recommend or rule out any test, treatment or medication, and it cannot tell you what your own plan will pay. Coverage rules, fee schedules and dispute thresholds change. For decisions about whether you need this test, consult a board-certified primary care physician or endocrinologist; for decisions about what it will cost you, consult your plan’s member services and the billing office of the facility drawing your blood.
The two routes an A1C test can be billed under
Almost every confusing A1C bill in the United States comes down to one distinction: whether the test was ordered as screening or as monitoring. These are separate billing events with separate rules, and the reason recorded on the order decides which one applies.
Route one: screening, when you have no diabetes diagnosis
You have no diabetes diagnosis and no symptoms prompting the test. The order exists to find out whether something is there. This is the route that federal preventive-coverage rules are built around.
Route two: monitoring, when you already have one
You have a diagnosis, and the test tracks how your management is going over time. Medicare’s national coverage rule describes glycated hemoglobin testing exactly this way — as a tool for the management and control of diabetes, not for diagnosing it.
What the code on your bill tells you
Both routes are usually billed under the same procedure code, CPT 83036, which stands for “Hemoglobin; glycosylated (A1c).” Seeing it on an itemized bill confirms which test you were charged for, though not which route it traveled. If the codes on your bill are what you are trying to decode, the code-by-code guide to reading a lab bill goes deeper than this page does.
| Route | Who is on it | What rule governs it | What this route does NOT cover |
|---|---|---|---|
| Screening | No diabetes diagnosis; no symptoms prompting the test | A statutory preventive benefit, applied through your plan’s preventive-services list | Anyone already diagnosed; any test ordered because of a symptom or a previous result |
| Monitoring | Already diagnosed; the test tracks management | Medical-necessity coverage rules, including Medicare’s national coverage determination for glycated hemoglobin | Testing beyond the documented frequency limits; testing for the purpose of making a diagnosis |
Source note: route descriptions taken from the coverage documents themselves — CMS National Coverage Determination 190.21 and the federal preventive-services list published on HealthCare.gov.
Why the same blood test has two different prices
The two routes exist because two separate pieces of federal machinery cover the same test, and they were built more than twenty years apart. Neither is wrong. They answer different questions.
A coverage rule written for management, not for screening
Medicare’s national coverage rule for glycated hemoglobin testing has been in effect since November 2002. It describes the test as a way to assess long-term glucose control, states plainly that these tests are not considered medically necessary for diagnosing diabetes, and sets frequency expectations for people being monitored.
That same document also says that tests performed for screening purposes, in the absence of signs, symptoms or personal history of disease, are not covered — except as explicitly authorized by statute.
The screening benefit came later, and separately
That exception is the whole story. Diabetes screening is a statutory preventive benefit, sitting outside the medical-necessity rules, and the A1C was added to the list of tests that can satisfy it relatively recently.
CMS’s own laboratory fee-schedule guidance puts it in one line: lab screening is not covered for patients with no personal disease history and no signs or symptoms, with some exceptions, like preventive services.
🔬 How It Works: Think of it as two doors into the same building. The screening door opens for people with no diagnosis, and preventive-coverage rules apply once you are through it. The monitoring door opens for people who already have a diagnosis, and medical-necessity rules apply instead. Your clinician chooses the door by recording why the test is being ordered, and that happens before your blood is drawn — which is why the price is settled earlier than most people realize.
What this means for a repeat test
A single A1C is rarely the end of it. A result near a decision threshold is normally confirmed with a second test, because measurement variation is real and a diagnosis built on one number is a diagnosis built on one number — this is why a second A1C is standard practice rather than an upsell.
Here is the part worth knowing in advance: a repeat test ordered because of your last result is being ordered for a reason, and a test ordered for a reason is not screening. That does not make it wrong, unnecessary, or something to avoid. It makes it a different billing event, and it is worth asking about before the draw rather than discovering it afterwards.
If your result landed in the borderline band, what doctors check after a borderline result sets out the clinical path. If it landed in the diabetes range, what happens after a result in the diabetes range does the same.
Why you should not ask for it to be coded differently
Once you understand that screening is the cheaper route, there is an obvious temptation. Resist it.
The reason recorded on an order has to reflect why the test was actually ordered. Asking a clinician or a billing office to record something else is asking them to misstate a claim, and it exposes both of you. Ask what the reason will be, and ask why — never ask for it to be changed.
⚠️ Clinical Warning: Cost is not a reason to skip or postpone a confirming A1C. A test ordered to check an abnormal result exists to establish whether that result was real, and delaying it delays an answer that may change your treatment. If the cost is the obstacle, the routes in section six are the way through it — not skipping the test.
What your insurance has to cover, and what it doesn’t
Marketplace plans and many other plans must cover a listed set of preventive services without charging a copayment or coinsurance, and that holds even if you have not met your yearly deductible. Diabetes screening is on that list. But the coverage arrives with conditions attached, and the conditions are where the surprises live.
What plans must cover with no copayment or coinsurance
The federal list of preventive services adult plans must cover includes diabetes screening, and the no-cost-sharing rule applies before the deductible is met rather than after it.
One precision point that almost no consumer page prints: the federal list names a service — Type 2 diabetes screening — not a specific test. Which test satisfies that service is a clinical and plan-level question, not something the list settles. The list also attaches eligibility criteria to that entry, and those criteria are a subject of their own.
The conditions attached — in network, and genuinely preventive
HealthCare.gov states two things in the same breath that are easy to read separately. These services are generally covered at no cost when provided by an in-network medical provider — and, in the site’s own words, “$0 cost isn’t guaranteed in all cases.”
Out-of-network draws, a lab your plan does not contract with, or a test that is genuinely diagnostic rather than preventive can each move you off the no-cost-sharing path. None of that is a billing error.
If the bill has already arrived
A preventive test that generates a bill is a common and specific problem with a specific set of causes, and why a preventive blood test can still generate a bill works through them properly. The same question for a metabolic panel is covered in whether a CMP is covered by insurance, and the mechanics are identical.
✅ Patient Action: Before the draw, ask the ordering office one question: “What diagnosis reason will go on this order?” Ask your plan’s member services a second: “Is this facility in network for lab work?” Those two answers, together, predict most of what you will owe.
How Medicare pays for an A1C, on both routes
Medicare beneficiaries usually pay nothing for an A1C on either route. The reasons are completely different, the conditions are different, and knowing which one you are relying on matters when something goes wrong.
The screening benefit, and the condition attached to it
Medicare’s consumer coverage page for diabetes screenings names A1C tests among the covered screening tests, states that you pay nothing if your health care provider accepts assignment, and sets the benefit at up to two screenings each year, within twelve months of your most recent one. That assignment condition is not decoration — it is the thing that makes the zero real.
That page also lists what the amount you could owe depends on: other insurance you hold, what your provider charges, whether they accept assignment, the type of facility, and where you get the test done. Five variables, on a federal page, and not one of them is the test itself.
The monitoring route, and why lab work is treated differently
If you already have a diagnosis, your A1C is monitoring, and the screening benefit does not apply to you at all. A different rule usually produces the same result: under the Medicare Clinical Laboratory Fee Schedule, the Part B deductible and coinsurance do not apply to services paid under that schedule.
Monitoring also carries documented frequency expectations, and testing beyond them needs a documented reason. That interval question belongs to its own article — how often an A1C is repeated covers the clinical cadence and the Medicare limits together. The same structure applies to other panels, as how Medicare handles a cholesterol test shows.
If you are handling this for a parent
You do not need a medical background to check a parent’s lab bill. Confirm the facility accepts assignment before the appointment, keep the Medicare Summary Notice that arrives afterwards, and compare it line by line against any bill from the provider. If the two disagree, that discrepancy — not the amount — is what to raise first.
🩺 Physician Note: A common point of confusion is the belief that a diabetes diagnosis makes every future A1C “free preventive care.” It does not. A diagnosis moves you permanently onto the monitoring route, where a different rule set applies. Under Original Medicare that usually still means no cost sharing for the lab work; under a commercial plan it can mean your deductible applies.
Paying cash: how to find the price before the draw
If you are uninsured or choosing not to use your insurance, you have a federal right that most people have never heard of: a written estimate of what you will be charged, before you receive the service. It is called a good faith estimate, and it is worth more than any range this page could publish.
Ask for a good faith estimate, in writing
Under the No Surprises requirements, effective since January 2022, providers and facilities must give uninsured or self-pay individuals a good faith estimate of expected charges once a service is scheduled — and must also provide one on request, whether or not you schedule anything.
Say this at the front desk, or on the phone: “I’m self-pay. I’d like a written good faith estimate for this lab work before I schedule.” You are not asking a favor. You are asking for something they are required to produce.
What to do if the bill comes in far higher
If the bill exceeds the estimate by enough, a federal dispute process exists, and an independent third party — not the provider — decides what you actually owe.
📊 Clinical Data Point: The patient-provider dispute resolution process is available to uninsured or self-pay patients billed at least $400 more than the expected charges on their good faith estimate — Source: Centers for Medicare & Medicaid Services, No Surprises Act guidance, page last modified April 2025.
Four protections apply while a dispute is open, and they answer the fear that stops most people from starting one. During the process, providers may not move the bill into collections or threaten to; must pause collections if the bill is already there; cannot collect late fees on the unpaid amount; and cannot retaliate against you for disputing.
Lower-cost places the test is done
Where the blood is drawn changes the price, which is why it appears on Medicare’s own list of variables. Hospital outpatient departments, independent labs and community health centers are three different price environments for identical work — why the same panel costs differently at a hospital and a lab sets out why.
Federally qualified health centers charge on a sliding scale based on income. Direct-to-consumer lab services let you order and pay for testing yourself in many states, at published prices. And federal and state assistance programs exist for people who cannot meet the cost of diabetes care — the NIDDK’s guide to financial help with diabetes care, last reviewed in 2019, maps the programs and the local health-center finder, though its cost figures are well out of date.
The same cash-pay ground for another panel is covered in what a lipid panel costs without insurance, and the procedure is the same whichever test you need.
What this page can’t tell you about your own bill
Being honest about the limits here is more useful than a confident number would be.
Why we don’t publish a price for this test
We do not print a national average for an A1C, because there isn’t one. Medicare’s own coverage page lists five separate variables that determine what you owe, and a figure that ignores all five will not match your bill. A number that turns out to be wrong is worse than no number, so we have given you the procedure for getting your own instead.
What we won’t recommend
We do not recommend or link any at-home A1C product on this page, and we do not earn anything from testing services mentioned here. The reason comes from our own sources rather than from caution: point-of-care and home-device results are not intended for diagnosis, CMS maintains an entirely separate procedure code for an A1c run on a home-use device, and public health guidance is to follow up with your own clinician after a health-fair or pharmacy result. If you want the comparison itself, how at-home blood tests compare with a lab draw covers it for a different panel.
We have also left the site’s calculators off this page deliberately. None of them can tell you what a test will cost, and putting one here would suggest otherwise.
Three questions that get you a real number
- To the ordering office: “What diagnosis reason will be on this order?”
- To your plan, or to the lab if you are self-pay: “Is this facility in network?” — or, self-pay, “May I have a written good faith estimate?”
- To the billing office, if a bill arrives: “May I have an itemized bill with the procedure codes?”
A1C test cost: common questions
1. How much does an A1C test cost?
There is no single national price. What you pay for an a1c test cost depends on whether you have coverage and why the test was ordered, plus what your provider charges and where the blood is drawn — Medicare’s own coverage page lists five separate variables. The reliable way to get your own figure is to ask for a written estimate before the draw.
2. Is an A1C test covered by insurance?
Marketplace plans and many others must cover listed preventive services, including diabetes screening, without a copayment or coinsurance, even before your deductible is met. That applies when the provider is in network, and HealthCare.gov states that $0 cost is not guaranteed in all cases. A test ordered for a diagnostic reason follows different rules.
3. Why did I get a bill for a test I was told was preventive?
Usually because the test was not billed as preventive. A test ordered because of a symptom, an existing diagnosis or a previous abnormal result is a diagnostic or monitoring event rather than a screening one, and an out-of-network draw can have the same effect. Neither is necessarily a billing error, and both are worth checking on an itemized bill.
4. Does Medicare pay for an A1C test?
Medicare’s coverage page for diabetes screenings names A1C tests among covered screening tests and states you pay nothing if your provider accepts assignment, up to two screenings each year. If you already have a diagnosis, the test is monitoring instead, and the laboratory fee schedule rules generally apply. Confirm assignment before scheduling.
5. Is the A1C free if I already have diabetes?
The preventive screening benefit does not apply to you at all once you have a diagnosis, because your A1C is monitoring rather than screening. Under Original Medicare that usually still means no cost sharing for the lab work, while under a commercial plan your deductible may apply. Ask your plan’s member services which of the two governs your a1c test cost.
6. What is the CPT code for an A1C test?
CPT 83036, “Hemoglobin; glycosylated (A1c),” is the code used for a standard laboratory A1C. CMS maintains a separate code for an A1c run on a device cleared for home use. Seeing 83036 on an itemized bill confirms which test you were charged for, though not whether it was billed as screening or monitoring.
7. How can I find out the price before the blood draw?
If you are uninsured or self-pay, ask for a written good faith estimate. Under the No Surprises requirements, providers must give one when a service is scheduled and also on request, whether or not you schedule. If you are insured, ask the ordering office what diagnosis reason will accompany the order and ask your plan whether the facility is in network.
8. What can I do if the bill is much higher than the estimate?
Uninsured or self-pay patients billed at least $400 more than their good faith estimate can start the federal patient-provider dispute resolution process, where an independent third party decides the amount owed. While a dispute is open, the provider may not move the bill to collections, must pause collections already started, cannot charge late fees, and cannot retaliate.
9. Is a repeat A1C billed the same way as the first one?
Not necessarily. A repeat test ordered because of your previous result is being ordered for a reason, which generally makes it a diagnostic or monitoring event rather than screening. That is not a reason to skip it — a confirming test exists to establish whether the first result was real, so ask the ordering clinician what reason will be recorded.
10. Can I ask my doctor to code it as screening so it’s free?
No. The reason recorded on an order has to reflect why the test was genuinely ordered, and asking for something else is asking a clinician or billing office to misstate a claim. You can and should ask what reason will be recorded and why — and if cost is the barrier, a good faith estimate and lower-cost draw locations are the legitimate routes.
11. Where can I get an A1C test cheaply without insurance?
Prices differ by setting rather than by test, so the same work costs differently at a hospital outpatient department, an independent lab, and a community health center. Federally qualified health centers charge on a sliding scale based on income, and direct-to-consumer lab services publish their prices in many states. Ask for a written estimate wherever you go.
What to do before your next A1C
The useful thing to carry away is not a number. It is that the number was decided before your blood was drawn, by the reason written on the order and by where you chose to have it done.
That means it is knowable in advance, and mostly it is knowable by asking two people one question each. Ask the ordering office what reason will be on the order. Ask your plan whether the facility is in network — or, if you are paying cash, ask the facility for a written good faith estimate.
If a bill arrives that does not match what you expected, ask for an itemized version with the procedure codes before you pay it or dispute it. And when you are ready to make sense of the result rather than the invoice, what your A1C result actually tells you is the place to start.
About this content
How this article was put together: researched from recognised health sources, drafted with the help of AI tools, and edited by hand, with sources linked throughout.
Sameer Patel is the founder and editor of My Medicine Advisor. He is not a doctor or medical professional — before starting this site he worked in banking,…
Medical disclaimer
The content on MyMedicineAdvisor is provided for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Health information on this website should not be used to diagnose, treat, cure, or prevent any condition without guidance from a qualified healthcare professional. Always seek the advice of your doctor, physician, or another licensed healthcare provider with any questions you may have regarding a medical condition, symptoms, medications, or treatment decisions.
